FibroGen: 4Q Earnings Snapshot

SAN FRANCISCO (AP) _ FibroGen Inc. (FGEN) on Monday reported a loss of $58.6 million in its fourth quarter.

On a per-share basis, the San Francisco-based company said it had a loss of 64 cents.

The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.

The biotech drug developer posted revenue of $65 million in the period, also falling short of Street forecasts. Six analysts surveyed by Zacks expected $86.7 million.

For the year, the company reported that its loss widened to $189.3 million, or $2.11 per share. Revenue was reported as $176.3 million.

FibroGen shares have risen 36% since the beginning of the year. In the final minutes of trading on Monday, shares hit $50.53, an increase of 25% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN